S&P 500   4,210.24
DOW   33,309.51
QQQ   325.93
The How And Why of Investing in Oil Stocks
Average 126% gains – NO losers!?   (Ad)pixel
The How and Why of Investing in Gold Stocks
Workhorse Group Is Ready To Get Back On The Horse 
A Rounded Bottom In Draftkings, Inc Begins To Reverse Course
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Trump says he took the Fifth in NY civil investigation
Closing prices for crude oil, gold and other commodities
Wall Street roars after inflation cools more than expected
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
S&P 500   4,210.24
DOW   33,309.51
QQQ   325.93
The How And Why of Investing in Oil Stocks
Average 126% gains – NO losers!?   (Ad)pixel
The How and Why of Investing in Gold Stocks
Workhorse Group Is Ready To Get Back On The Horse 
A Rounded Bottom In Draftkings, Inc Begins To Reverse Course
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Trump says he took the Fifth in NY civil investigation
Closing prices for crude oil, gold and other commodities
Wall Street roars after inflation cools more than expected
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
S&P 500   4,210.24
DOW   33,309.51
QQQ   325.93
The How And Why of Investing in Oil Stocks
Average 126% gains – NO losers!?   (Ad)pixel
The How and Why of Investing in Gold Stocks
Workhorse Group Is Ready To Get Back On The Horse 
A Rounded Bottom In Draftkings, Inc Begins To Reverse Course
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Trump says he took the Fifth in NY civil investigation
Closing prices for crude oil, gold and other commodities
Wall Street roars after inflation cools more than expected
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
S&P 500   4,210.24
DOW   33,309.51
QQQ   325.93
The How And Why of Investing in Oil Stocks
Average 126% gains – NO losers!?   (Ad)pixel
The How and Why of Investing in Gold Stocks
Workhorse Group Is Ready To Get Back On The Horse 
A Rounded Bottom In Draftkings, Inc Begins To Reverse Course
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Trump says he took the Fifth in NY civil investigation
Closing prices for crude oil, gold and other commodities
Wall Street roars after inflation cools more than expected
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
NYSE:OMI

Owens & Minor - OMI Stock Forecast, Price & News

$34.60
+1.33 (+4.00%)
(As of 08/10/2022 12:00 AM ET)
Add
Compare
Today's Range
$33.55
$34.81
50-Day Range
$29.71
$36.64
52-Week Range
$29.50
$49.11
Volume
594,607 shs
Average Volume
784,337 shs
Market Capitalization
$2.64 billion
P/E Ratio
17.13
Dividend Yield
N/A
Price Target
$50.33

Owens & Minor MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
45.5% Upside
$50.33 Price Target
Short Interest
Bearish
8.66% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.56
Upright™ Environmental Score
News Sentiment
0.11mentions of Owens & Minor in the last 14 days
Based on 15 Articles This Week
Insider Trading
Selling Shares
$518,912 Sold Last Quarter
Proj. Earnings Growth
16.61%
From $3.19 to $3.72 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.79 out of 5 stars

Medical Sector

62nd out of 1,108 stocks

Medical & Hospital Equipment Industry

1st out of 3 stocks

OMI stock logo

About Owens & Minor (NYSE:OMI) Stock

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. It provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.

Owens & Minor Stock Performance

NYSE:OMI traded up $1.33 during trading hours on Wednesday, reaching $34.60. 597,966 shares of the company's stock were exchanged, compared to its average volume of 784,337. Owens & Minor has a 1-year low of $29.50 and a 1-year high of $49.11. The firm has a market capitalization of $2.64 billion, a price-to-earnings ratio of 17.13, a P/E/G ratio of 1.32 and a beta of 0.55. The company has a quick ratio of 0.58, a current ratio of 1.55 and a debt-to-equity ratio of 2.68. The company has a 50-day moving average of $32.91 and a 200 day moving average of $37.82.

Owens & Minor (NYSE:OMI - Get Rating) last posted its quarterly earnings results on Wednesday, August 3rd. The company reported $0.76 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.76. Owens & Minor had a net margin of 1.56% and a return on equity of 26.66%. The firm had revenue of $2.50 billion during the quarter, compared to analysts' expectations of $2.53 billion. During the same period in the prior year, the company posted $1.06 earnings per share. The firm's revenue for the quarter was up .4% on a year-over-year basis. Research analysts anticipate that Owens & Minor will post 3.19 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on OMI. Credit Suisse Group lowered their target price on shares of Owens & Minor from $43.00 to $37.00 and set a "neutral" rating for the company in a report on Thursday, August 4th. Robert W. Baird lowered their target price on shares of Owens & Minor from $70.00 to $62.00 and set an "outperform" rating for the company in a report on Thursday, August 4th. StockNews.com cut shares of Owens & Minor from a "buy" rating to a "hold" rating in a research note on Wednesday, May 11th. Finally, Citigroup decreased their price target on shares of Owens & Minor from $58.00 to $52.00 in a research note on Thursday, August 4th. Two equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, Owens & Minor has a consensus rating of "Hold" and an average target price of $50.33.

Insiders Place Their Bets

In other Owens & Minor news, Director Gwendolyn M. Bingham sold 7,600 shares of the business's stock in a transaction that occurred on Thursday, May 12th. The stock was sold at an average price of $35.32, for a total transaction of $268,432.00. Following the transaction, the director now owns 22,184 shares in the company, valued at approximately $783,538.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Gwendolyn M. Bingham sold 7,600 shares of the company's stock in a transaction that occurred on Thursday, May 12th. The stock was sold at an average price of $35.32, for a total value of $268,432.00. Following the sale, the director now owns 22,184 shares in the company, valued at approximately $783,538.88. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, COO Jeffrey T. Jochims sold 8,000 shares of the company's stock in a transaction that occurred on Friday, July 1st. The stock was sold at an average price of $31.31, for a total value of $250,480.00. Following the completion of the sale, the chief operating officer now owns 195,956 shares in the company, valued at approximately $6,135,382.36. The disclosure for this sale can be found here. 4.09% of the stock is currently owned by insiders.

Receive OMI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Owens & Minor and its competitors with MarketBeat's FREE daily newsletter.

OMI Stock News Headlines

Owens & Minor (NYSE:OMI) Price Target Cut to $62.00
Owens & Minor (NYSE:OMI) PT Lowered to $37.00
Owens & Minor (NYSE:OMI) Shares Gap Down to $36.64
Owens & Minor Shares Slip On FY22 Outlook Cut
Owens & Minor Q2 Profit Matches Estimates
Owens & Minor Inc - Stock Financials OMI
Owens & Minor Inc (OMI) Trading Report
See More Headlines
Receive OMI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Owens & Minor and its competitors with MarketBeat's FREE daily newsletter.

OMI Company Calendar

Last Earnings
8/03/2022
Today
8/10/2022
Next Earnings (Estimated)
11/02/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Medical & hospital equipment
Sub-Industry
Health Care Distributors
Sector
Medical
CUSIP
69073210
Employees
17,300
Year Founded
1882

Price Target and Rating

Average Stock Price Forecast
$50.33
High Stock Price Forecast
$62.00
Low Stock Price Forecast
$37.00
Forecasted Upside/Downside
+45.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$221.59 million
Pretax Margin
1.89%

Debt

Sales & Book Value

Annual Sales
$9.79 billion
Cash Flow
$5.61 per share
Book Value
$12.44 per share

Miscellaneous

Free Float
73,129,000
Market Cap
$2.64 billion
Optionable
Optionable
Beta
0.55

Social Links















OMI Stock - Frequently Asked Questions

Should I buy or sell Owens & Minor stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Owens & Minor in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" OMI shares.
View OMI analyst ratings
or view top-rated stocks.

What is Owens & Minor's stock price forecast for 2022?

2 Wall Street analysts have issued 1 year price objectives for Owens & Minor's shares. Their OMI share price forecasts range from $37.00 to $62.00. On average, they expect the company's share price to reach $50.33 in the next twelve months. This suggests a possible upside of 45.5% from the stock's current price.
View analysts price targets for OMI
or view top-rated stocks among Wall Street analysts.

How have OMI shares performed in 2022?

Owens & Minor's stock was trading at $43.50 at the start of the year. Since then, OMI stock has decreased by 20.5% and is now trading at $34.60.
View the best growth stocks for 2022 here
.

When is Owens & Minor's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our OMI earnings forecast
.

How were Owens & Minor's earnings last quarter?

Owens & Minor, Inc. (NYSE:OMI) announced its quarterly earnings results on Wednesday, August, 3rd. The company reported $0.76 EPS for the quarter, meeting the consensus estimate of $0.76. The firm had revenue of $2.50 billion for the quarter, compared to analysts' expectations of $2.53 billion. Owens & Minor had a net margin of 1.56% and a trailing twelve-month return on equity of 26.66%. Owens & Minor's revenue was up .4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.06 earnings per share.

How often does Owens & Minor pay dividends? What is the dividend yield for Owens & Minor?

Owens & Minor announced a quarterly dividend on Friday, October 29th. Stockholders of record on Wednesday, December 15th will be given a dividend of $0.002 per share on Friday, December 31st. This represents a $0.01 annualized dividend and a dividend yield of 0.02%. The ex-dividend date is Tuesday, December 14th.
Read our dividend analysis for OMI
.

What guidance has Owens & Minor issued on next quarter's earnings?

Owens & Minor issued an update on its FY 2022 earnings guidance on Wednesday, August, 10th. The company provided EPS guidance of $2.85-$3.15 for the period, compared to the consensus EPS estimate of $3.34. The company issued revenue guidance of $9.80 billion-$10.10 billion, compared to the consensus revenue estimate of $10.15 billion.

What is Ed Pesicka's approval rating as Owens & Minor's CEO?

36 employees have rated Owens & Minor Chief Executive Officer Ed Pesicka on Glassdoor.com. Ed Pesicka has an approval rating of 65% among the company's employees.

What other stocks do shareholders of Owens & Minor own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Owens & Minor investors own include Advanced Micro Devices (AMD), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Micron Technology (MU), NVIDIA (NVDA), Applied Materials (AMAT), Enterprise Products Partners (EPD), Johnson & Johnson (JNJ) and Cisco Systems (CSCO).

What is Owens & Minor's stock symbol?

Owens & Minor trades on the New York Stock Exchange (NYSE) under the ticker symbol "OMI."

Who are Owens & Minor's major shareholders?

Owens & Minor's stock is owned by many different retail and institutional investors. Top institutional shareholders include William Blair Investment Management LLC (3.61%), Allspring Global Investments Holdings LLC (2.81%), Brown Advisory Inc. (1.99%), Artemis Investment Management LLP (1.66%), Eagle Asset Management Inc. (0.84%) and Principal Financial Group Inc. (0.69%). Insiders that own company stock include Andrew G Long, Andrew G Long, Christopher M Lowery, Edward A Pesicka, Gwendolyn M Bingham, Jeffrey T Jochims, Jeffrey T Jochims, Jonathan A Leon, Lawrence Lacerte, Mark P Zacur, Michael Wayne Lowry, Nicholas J Pace, Robert J Henkel, Robert Weideman and Shana Carol Neal.
View institutional ownership trends
.

How do I buy shares of Owens & Minor?

Shares of OMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Owens & Minor's stock price today?

One share of OMI stock can currently be purchased for approximately $34.60.

How much money does Owens & Minor make?

Owens & Minor (NYSE:OMI) has a market capitalization of $2.64 billion and generates $9.79 billion in revenue each year. The company earns $221.59 million in net income (profit) each year or $2.02 on an earnings per share basis.

How many employees does Owens & Minor have?

The company employs 17,300 workers across the globe.

Does Owens & Minor have any subsidiaries?

The following companies are subsidiares of Owens & Minor: 500 Expressway Drive South LLC, 5nq, AVID Medical Inc., Access Diabetic Supply, Access Diabetic Supply L.L.C., Access Respiratory Supply Inc, Arabian Medical Products Manufacturing Company, ArcRoyal, ArcRoyal Holdings Unlimited Company, ArcRoyal Unlimited Company, Barista Acquisition I LLC, Barista Acquisition II LLC, Byram Healthcare Centers, Byram Healthcare Centers Inc., Byram Holdings I Inc., Clinical Care Services L.L.C., Cyrus Medical Systems, Diabetes Specialty Center L.L.C., Fusion 5 Inc., Halyard Health - S&IP, Halyard Malaysia SND BHD, Halyard North Carolina LLC, HealthCare Logistics Services, Key Diabetes Supply Co., La Ada de Acuna S. de R.L. de C.V., MAI Acquisition Corp., MIRA Medsource (Malaysia) SDN. BHD., McKesson's Acute-Care Medical, Medegen Newco LLC, Medical Action Industries, Medical Action Industries Inc., Medical Supply Group Inc., Mira MEDsource (Shanghai) Co. LTD, Mira MEDsource Holding Company Limited, Movianto, Nalvest Limited, O and M Halyard South Africa Pty Ltd, O&M Brasil Consultoria Ltda, O&M Byram Holdings GP, O&M Funding LLC, O&M Halyard Australia PTY LTD, O&M Halyard Belgium, O&M Halyard Canada Inc., O&M Halyard France, O&M Halyard Germany GmbH, O&M Halyard Health India Private Limited, O&M Halyard Honduras S.A. de C.V., O&M Halyard Inc., O&M Halyard International Unlimited Company, O&M Halyard Ireland Limited, O&M Halyard Japan GK, O&M Halyard Mexico S. de R.L. de C.V., O&M Halyard Netherlands B.V., O&M Halyard Singapore PTE Ltd, O&M Halyard UK Limited, O&M Healthcare Italia S.R.L., O&M International Healthcare C.V., O&M Worldwide LLC, OMSolutions International Inc., Owens & Minor Canada Inc., Owens & Minor Distribution Inc., Owens & Minor Global Resources LLC, Owens & Minor Global Services Unlimited Company, Owens & Minor Healthcare Supply Inc., Owens & Minor Inc., Owens & Minor Inc. Executive Deferred Compensation Trust, Owens & Minor International Logistics Inc., Owens & Minor International Unlimited Company, Owens & Minor Ireland Unlimited Company, Owens & Minor Jersey Holdings Limited, Owens & Minor Jersey Unlimited, Owens & Minor Medical Inc., Safeskin Medical & Scientific (Thailand) Ltd., Stuart Medical, and The Burrows Company.
Read More

When was Owens & Minor founded?

Owens & Minor was founded in 1882.

How can I contact Owens & Minor?

Owens & Minor's mailing address is 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA, 23261. The official website for the company is www.owens-minor.com. The company can be reached via phone at (804) 723-7000, via email at truitt.allcott@owens-minor.com, or via fax at 804-723-7100.

This page (NYSE:OMI) was last updated on 8/11/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.